Large scientific program will reinforce the ongoing clinical and
patient benefits of its robust portfolio
Highlights include new product launches in phacoemulsification,
visualization for the Cataract Refractive Suite and innovations in
intraoperative aberrometry and AT-IOLs
Onsite events for surgeons demonstrate Alcon’s continued commitment
to world-class training, education
GENEVA–(BUSINESS WIRE)–Regulatory News:
Alcon, the global leader in eye care dedicated to helping people see
brilliantly, will feature new clinical data along with innovative
product designs and technology for the Cataract Refractive Suite during
the American Society of Cataract and Refractive Surgery (ASCRS) 2019
annual meeting, taking place May 3-7 in San Diego, CA. The company –
which recently became an independent, publicly-traded entity – will be
included in 170 scientific abstracts at the meeting, underscoring its
efforts to support surgeons with the most complete line of ophthalmic
“It’s an exciting time at Alcon. We are the largest independent eye care
device company in the world, with a powerful plan for innovation and
growth, fueled in part by the data and technology we will be showcasing
at ASCRS this year,” said Sergio Duplan, Region President, North
America, Alcon. “This meeting offers another opportunity to demonstrate
our focus in delivering advancements in areas we know are important to
our customers – especially personalization, precision and efficiency
during surgery to deliver better patient outcomes.”
Innovating in Phacoemulsification (Phaco) Technology
In an effort to improve safety, consistency and control during cataract
surgery, Alcon will launch the ACTIVE SENTRY® Handpiece and
INTREPID® Hybrid Tip. The ACTIVE SENTRY® Handpiece
is the first and only phaco handpiece with a built-in fluidics pressure
sensor that detects pressure in real time and communicates with the
CENTURION® Vision System. The INTREPID® Hybrid Tip
is an update to the popular INTREPID® BALANCED Tip, and
includes a rounded polymer edge designed to reduce the risk of capsular
tears and improve patient safety in the OR.1 Several posters
and presentations will highlight the clinical significance of these
Monday, May 6
Paper Presentation: Occlusion Break Surge Volume Reduction
with Active Sentry, Presented by Dr. Kevin M. Miller (3:40 – 3:45
p.m., San Diego Convention Center [SDCC], Upper Level, Room 1B).
- Paper Presentation: Occlusion Break Surge Volume Reduction
Tuesday, May 7
Paper Presentation: Evaluation of the Capsular Safety of a
Novel Hybrid Phacoemulsification Tip in a Cadaver Eye Model,
Presented by Dr. Caleb L. Shumway, et al. (10:07 – 10:12 a.m.,
SDCC, Upper Level, Room 1A).
- Paper Presentation: Evaluation of the Capsular Safety of a
Changing the Paradigm in Visualization
Alcon will feature two technologies that aim to improve surgeon
visualization during cataract surgery.
The new LuxOR Revalia™ Ophthalmic Microscope delivers enhanced
visualization during all stages of cataract surgery through unique and
personalized LED illumination technology.2
NGENUITY® 3D Visualization System will now be available in
the Cataract Refractive Suite to bring unprecedented 3D visualization
for the anterior space.3 In addition to offering greater
depth of focus during cataract surgery, the system enables a full view
of the surgical procedure for the entire OR staff, and enhances
training and teaching capabilities for residents and fellows. It also
allows the surgeon to operate with a more ergonomic posture during
Highlighting Advantages of Intraoperative Aberrometry
The ORA SYSTEM® powered by AnalyzOR™ Technology is the only
intraoperative aberrometer to bring precise, real-time tracking of
refractive outcomes for continual optimization during surgery. Key data
shared at the meeting will examine the results of using intraoperative
aberrometry versus pre-operative formulas.
Saturday, May 4
Paper Presentation: Refractive Outcomes Using
Intraoperative Aberrometry for Highly Myopic, Highly Hyperopic,
and Post-Refractive Eyes, Presented by Dr. Terry Kim, et al. (1:45
– 1:50 p.m., SDCC, Upper Level, Room 1B).
- Paper Presentation: Refractive Outcomes Using
Tuesday, May 7
Paper Presentation: Use of a Refractive Analysis Database
for Intraocular Lens Power Optimization in Cataract Surgery,
Presented by Dr. Robert J. Cionni et al. (9:00 – 9:05 a.m., SDCC,
Upper Level, Room 1B).
- Paper Presentation: Use of a Refractive Analysis Database
Alcon will be hosting a symposium titled Intra-Operative Aberrometry
(IOA) In Modern Cataract Refractive Surgery for Current and Future Users
Summit for existing or interested ORA SYSTEM® technology
users; the symposium will focus on ORA intraoperative aberrometry with
preoperative formulas. This event will be held on Friday, May 3 from
5:30 – 7:30 p.m., Marriott Marquis, San Diego Marina, Ballroom 10.
Examining the Benefits of Presbyopia-Correcting IOLs
Alcon’s ReSTOR® +2.5D ACTIVEFOCUS™ is the only multifocal
toric IOL that delivers uncompromised distance vision and unrivaled
stability.5-10 New data will be presented which looks at the
satisfaction of patients implanted with a ReSTOR® 2.5 and 3.0
add lens combination and the rotational stability with ACTIVEFOCUS™
Toric IOLs versus TECNIS® Toric IOLs*.
Saturday, May 4
Paper Presentation: Patient-Reported Satisfaction and
Spectacle Independence Using Mini-monovision with the Multifocal
IOLs in Cataract Surgery, Presented by Dr. John A. Hovanesian
(2:10 – 2:15 p.m., SDCC, Upper Level, Room 7B).
- Paper Presentation: Patient-Reported Satisfaction and
Tuesday, May 7
Paper Presentation: Residual Astigmatism after IOL
Placement: An Update in Rotational Trends, Presented by Dr. Brent
A. Kramer, et al. (10:32 – 10:37 a.m., SDCC, Upper Level, Room 1B).
- Paper Presentation: Residual Astigmatism after IOL
Alcon will also have the following events onsite:
The Focal Point: Teachable Moments in Cataract Surgery from the
Alcon Experience Academy, during which world-class surgeons will
discuss cataract cases via a wide-screen, high-definition 3D video
presentation. The event will take place on Saturday, May 4 from 6:15 –
7:45 p.m., SDCC, Hall E.
Surgeon to Surgeon gives surgeons who visit the Alcon booth
#921 the opportunity to talk one-on-one with other surgeons about some
of the most innovative eye care technologies in the industry.
Alcon (ALC): Our Next Chapter lunch event enables attendees to
learn more about the new, independent Alcon including a look at how
the company plans to shape the future of ophthalmology. This will take
place on Sunday, May 5 from 11:30 – 1:00 PM, SDCC, Hall E.
Visit Alcon booth #921 to learn more and experience hands-on
demonstrations of the Alcon cataract and refractive portfolio, including
our newest innovations.
All educational content of the ASCRS•ASOA Annual Meeting is planned
by its program committee, and ASCRS•ASOA does not endorse, promote,
approve, or recommend the use of any products, devices, or services.
The CENTURION® Vision system is indicated for
emulsification, separation, irrigation, and aspiration of cataracts,
residual cortical material and lens epithelial cells, vitreous
aspiration and cutting associated with anterior vitrectomy, bipolar
coagulation, and intraocular lens injection. Appropriate use of CENTURION®
Vision System parameters and accessories is important for successful
procedures. Please refer to the ORA SYSTEM® Operator’s Manual
for a complete description of proper use and maintenance, as well as a
complete list of contraindications, warnings and precautions.
About LuxOR Revalia™ Ophthalmic Microscope
The LuxOR Revalia™ Ophthalmic Microscope features unique technologies
designed to optimize both anterior and posterior procedures, providing
superior visualization1 for every type of ophthalmic surgery.
As with all ophthalmic microscopes, exposure during aphakia should be
limited to reduce the risk of damage. During aphakia, limit exposure to
red reflex light to no more than 7 minutes.
3D Visualization System
The NGENUITY® 3D Visualization System consists of a 3D
stereoscopic, high-definition digital video camera and workstation to
provide magnified stereoscopic images of objects during micro-surgery.
It acts as an adjunct to the surgical microscope during surgery
displaying real-time images or images from recordings. Please refer to
the User Manual for a complete list of appropriate uses, warnings and
About ORA SYSTEM®
powered by AnalyzOR™
The ORA SYSTEM® technology utilizes wavefront aberrometry
data to measure and analyze the refractive power of the eye (i.e.
sphere, cylinder, and axis measurements) to support cataract surgical
procedures. Please refer to the User Manual for a complete list of
appropriate uses, warnings and precautions.
+2.5D with ACTIVEFOCUS™ optical design
The AcrySof® IQ ReSTOR® Posterior Chamber
Intraocular Multifocal IOLs include AcrySof® IQ ReSTOR®
and AcrySof® IQ ReSTOR® Toric and are intended for
primary implantation for the visual correction of aphakia secondary to
removal of a cataractous lens in adult patients with and without
presbyopia, who desire near, intermediate and distance vision with
increased spectacle independence. In addition, the AcrySof®
IQ ReSTOR® Toric IOL is intended to correct pre-existing
astigmatism. The lenses are intended to be placed in the capsular bag.
Careful preoperative evaluation and sound clinical judgment should be
used by the surgeon to decide the risk/benefit ratio before implanting a
lens in a patient with any of the conditions described in the Directions
for Use labeling for each IOL. Some patients may experience visual
disturbances and/or discomfort due to multifocality, especially under
dim light conditions. Prior to surgery, physicians should provide
prospective patients with a copy of the Patient Information Brochure
available from Alcon informing them of possible risks and benefits
associated with the AcrySof® IQ ReSTOR® IOLs.
This press release contains “forward-looking statements” within the
meaning of the safe harbor provisions of the United States Private
Securities Litigation Reform Act of 1995. Forward-looking statements can
be identified by words such as: “anticipate,” “intend,” “commitment,”
“look forward,” “maintain,” “plan,” “goal,” “seek,” “believe,”
“project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,”
“should,” “will” and similar references to future periods.
Forward-looking statements are neither historical facts nor assurances
of future performance. Instead, they are based only on our current
beliefs, expectations and assumptions regarding the future of our
business, future plans and strategies, and other future conditions.
Because forward-looking statements relate to the future, they are
subject to inherent uncertainties and risks that are difficult to
predict. Some of these factors are discussed in our filings with the
United States Securities and Exchange Commission, including our Form
20-F. In particular, our expectations could be affected by uncertainties
regarding the success of our separation and spin-off from Novartis.
Should one or more of these uncertainties or risks materialize, or
should underlying assumptions prove incorrect, actual results may vary
materially from those anticipated. Therefore, you should not rely on any
of these forward-looking statements.
Forward-looking statements in this press release speak only as of the
date of its filing, and we assume no obligation to update
forward-looking statements as a result of new information, future events
Alcon helps people see brilliantly. As the global leader in eye care
with a heritage spanning more than seven decades, we offer the broadest
portfolio of products to enhance sight and improve people’s lives. Our
Surgical and Vision Care products touch the lives of more than 260
million people in over 140 countries each year living with conditions
like cataracts, glaucoma, retinal diseases and refractive errors. Our
more than 20,000 associates are enhancing the quality of life through
innovative products, partnerships with eye care professionals and
programs that advance access to quality eye care. Learn more at www.alcon.com.
- Alcon Data on File.
- Alcon Data on File.
Alcon Data on File. Yin L, Sarangapani R. Assessment of visual
attributes for NGENUITY® 3D Visualization System 1.0 for digitally
assisted vitreoretinal surgery. Alcon Modeling and Simulation.
Eckardt C, Paulo EB. HEADS-UP SURGERY FOR VITREORETINAL PROCEDURES: An
Experimental and Clinical Study. Retina. 2016 Jan;36(1):137–47.
- Alcon Data on File (Jul 2016).
- AcrySof® IQ ReSTOR® +2.5 D Multifocal Toric IOL Directions for Use.
Vega F, Alba-Bueno F, Millán MS, Varon C, Gil MA, Buil JA. Halo and
through-focus performance of four diffractive multifocal intraocular
lenses. Invest Ophthalmol Vis Sci. 2015;56(6):3967-3975 (study
conducted with corneal model eye with 0.28μ spherical aberration).
Wirtitsch MG, Findl O, Menapace R, et al. Effect of haptic design on
change in axial lens position after cataract surgery. J Cataract
Refract Surg. 2004;30(1):45-51.
Visser N, Bauer NJ, Nuijts RM. Toric intra-ocular lenses: historical
overview, patient selection, IOL calculation, surgical techniques,
clinical outcomes, and complications. J Cataract Refract Surg.
Potvin R, Kramer BA, Hardten DR, Berdahl JP. Toric intraocular lens
orientation and residual refractive astigmatism: an analysis. Clin
* TECNIS® is a registered trademark of
Johnson & Johnson.
817 551 4328 (office)
+1 682 321 2897
+ 1 41 589 112 110 (Geneva)
+ 1 817 615 2789 (Fort Worth)